Publication Information

{'id': 'https://openalex.org/W2066713758', 'doi': 'https://doi.org/10.1038/leu.2012.119', 'title': 'Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide', 'display_name': 'Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide', 'publication_year': 2012, 'publication_date': '2012-05-03', 'ids': {'openalex': 'https://openalex.org/W2066713758', 'doi': 'https://doi.org/10.1038/leu.2012.119', 'mag': '2066713758', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/22552008', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/3868310'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/leu.2012.119', 'pdf_url': 'https://www.nature.com/articles/leu2012119.pdf', 'source': {'id': 'https://openalex.org/S149476849', 'display_name': 'Leukemia', 'issn_l': '0887-6924', 'issn': ['0887-6924', '1476-5551'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://www.nature.com/articles/leu2012119.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5037376307', 'display_name': 'Antonia López-Girona', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I47396830', 'display_name': 'Bristol-Myers Squibb (Switzerland)', 'ror': 'https://ror.org/02xqc6638', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I4210091812', 'https://openalex.org/I47396830']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'A Lopez-Girona', 'raw_affiliation_strings': ['Celgene, San Diego, CA 92121, USA.'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, CA 92121, USA.', 'institution_ids': ['https://openalex.org/I47396830']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084626843', 'display_name': 'Derek Mendy', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'D Mendy', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010700890', 'display_name': 'Takumi Ito', 'orcid': 'https://orcid.org/0000-0002-9997-2664'}, 'institutions': [{'id': 'https://openalex.org/I114531698', 'display_name': 'Tokyo Institute of Technology', 'ror': 'https://ror.org/0112mx960', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I114531698']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'T Ito', 'raw_affiliation_strings': ['Solutions Research Laboratory, Tokyo Institute of Technology , Tokyo , Japan'], 'affiliations': [{'raw_affiliation_string': 'Solutions Research Laboratory, Tokyo Institute of Technology , Tokyo , Japan', 'institution_ids': ['https://openalex.org/I114531698']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5081568538', 'display_name': 'Karl N. Miller', 'orcid': 'https://orcid.org/0000-0002-6076-3136'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'K Miller', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043395223', 'display_name': 'Anita K. Gandhi', 'orcid': 'https://orcid.org/0000-0001-5512-1625'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A K Gandhi', 'raw_affiliation_strings': ['Celgene Corporation, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, Summit, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025670042', 'display_name': 'Jian Kang', 'orcid': 'https://orcid.org/0000-0003-1450-1810'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J Kang', 'raw_affiliation_strings': ['Celgene Corporation, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, Summit, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045832394', 'display_name': 'Satoki Karasawa', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I114531698', 'display_name': 'Tokyo Institute of Technology', 'ror': 'https://ror.org/0112mx960', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I114531698']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'S Karasawa', 'raw_affiliation_strings': ['Solutions Research Laboratory, Tokyo Institute of Technology , Tokyo , Japan'], 'affiliations': [{'raw_affiliation_string': 'Solutions Research Laboratory, Tokyo Institute of Technology , Tokyo , Japan', 'institution_ids': ['https://openalex.org/I114531698']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000871276', 'display_name': 'Gilles Carmel', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'G Carmel', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047370396', 'display_name': 'Pilgrim J. Jackson', 'orcid': 'https://orcid.org/0000-0002-2796-5297'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'P Jackson', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001662710', 'display_name': 'Mahan Abbasian', 'orcid': 'https://orcid.org/0009-0007-3341-4559'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M Abbasian', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062064828', 'display_name': 'Ali Mahmoudi', 'orcid': 'https://orcid.org/0000-0002-7992-346X'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A Mahmoudi', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041317994', 'display_name': 'Brian E. Cathers', 'orcid': 'https://orcid.org/0000-0003-2793-7533'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'B Cathers', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079316241', 'display_name': 'Emily Rychak', 'orcid': 'https://orcid.org/0000-0002-6363-5922'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'E Rychak', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054016372', 'display_name': 'Svetlana Gaidarova', 'orcid': 'https://orcid.org/0000-0003-2793-8472'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S Gaidarova', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086873087', 'display_name': 'R Chen', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R Chen', 'raw_affiliation_strings': ['Celgene Corporation, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, Summit, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102815745', 'display_name': 'Peter Schäfer', 'orcid': 'https://orcid.org/0000-0002-3880-0850'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'P H Schafer', 'raw_affiliation_strings': ['Celgene Corporation, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, Summit, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034882455', 'display_name': 'Hiroshi Handa', 'orcid': 'https://orcid.org/0000-0001-6656-9521'}, 'institutions': [{'id': 'https://openalex.org/I114531698', 'display_name': 'Tokyo Institute of Technology', 'ror': 'https://ror.org/0112mx960', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I114531698']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'H Handa', 'raw_affiliation_strings': ['Solutions Research Laboratory, Tokyo Institute of Technology , Tokyo , Japan'], 'affiliations': [{'raw_affiliation_string': 'Solutions Research Laboratory, Tokyo Institute of Technology , Tokyo , Japan', 'institution_ids': ['https://openalex.org/I114531698']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035786010', 'display_name': 'Tom Daniel', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'T O Daniel', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041666909', 'display_name': 'Jilly F. Evans', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J F Evans', 'raw_affiliation_strings': ['Celgene, San Diego, USA,'], 'affiliations': [{'raw_affiliation_string': 'Celgene, San Diego, USA,', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5111591940', 'display_name': 'Rajesh Chopra', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R Chopra', 'raw_affiliation_strings': ['Celgene Corporation, Summit, USA'], 'affiliations': [{'raw_affiliation_string': 'Celgene Corporation, Summit, USA', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3890, 'currency': 'EUR', 'value_usd': 4790, 'provenance': 'doaj'}, 'apc_paid': {'value': 3890, 'currency': 'EUR', 'value_usd': 4790, 'provenance': 'doaj'}, 'fwci': 21.037, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 737, 'citation_normalized_percentile': {'value': 0.999985, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '26', 'issue': '11', 'first_page': '2326', 'last_page': '2335'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cereblon', 'display_name': 'Cereblon', 'score': 0.9774523}, {'id': 'https://openalex.org/keywords/pomalidomide', 'display_name': 'Pomalidomide', 'score': 0.9737265}], 'concepts': [{'id': 'https://openalex.org/C2778540781', 'wikidata': 'https://www.wikidata.org/wiki/Q21112029', 'display_name': 'Cereblon', 'level': 5, 'score': 0.9774523}, {'id': 'https://openalex.org/C2778524551', 'wikidata': 'https://www.wikidata.org/wiki/Q7227206', 'display_name': 'Pomalidomide', 'level': 4, 'score': 0.9737265}, {'id': 'https://openalex.org/C2776063141', 'wikidata': 'https://www.wikidata.org/wiki/Q425681', 'display_name': 'Lenalidomide', 'level': 3, 'score': 0.9051521}, {'id': 'https://openalex.org/C2779609412', 'wikidata': 'https://www.wikidata.org/wiki/Q203174', 'display_name': 'Thalidomide', 'level': 3, 'score': 0.82583797}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.7106053}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.58356726}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.41457918}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.34699044}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.33295187}, {'id': 'https://openalex.org/C134459356', 'wikidata': 'https://www.wikidata.org/wiki/Q4274835', 'display_name': 'Ubiquitin ligase', 'level': 4, 'score': 0.2573967}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.23556489}, {'id': 'https://openalex.org/C25602115', 'wikidata': 'https://www.wikidata.org/wiki/Q407111', 'display_name': 'Ubiquitin', 'level': 3, 'score': 0.17240864}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.10912904}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.08992553}], 'mesh': [{'descriptor_ui': 'D000276', 'descriptor_name': 'Adjuvants, Immunologic', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D010447', 'descriptor_name': 'Peptide Hydrolases', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D048868', 'descriptor_name': 'Adaptor Proteins, Signal Transducing', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000276', 'descriptor_name': 'Adjuvants, Immunologic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D057809', 'descriptor_name': 'HEK293 Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077269', 'descriptor_name': 'Lenalidomide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010447', 'descriptor_name': 'Peptide Hydrolases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D044767', 'descriptor_name': 'Ubiquitin-Protein Ligases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D054875', 'descriptor_name': 'Ubiquitination', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/leu.2012.119', 'pdf_url': 'https://www.nature.com/articles/leu2012119.pdf', 'source': {'id': 'https://openalex.org/S149476849', 'display_name': 'Leukemia', 'issn_l': '0887-6924', 'issn': ['0887-6924', '1476-5551'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496085', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/22552008', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/leu.2012.119', 'pdf_url': 'https://www.nature.com/articles/leu2012119.pdf', 'source': {'id': 'https://openalex.org/S149476849', 'display_name': 'Leukemia', 'issn_l': '0887-6924', 'issn': ['0887-6924', '1476-5551'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319965', 'host_organization_name': 'Springer Nature', 'host_organization_lineage': ['https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Springer Nature'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.61, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 32, 'referenced_works': ['https://openalex.org/W1537559901', 'https://openalex.org/W1597238753', 'https://openalex.org/W1973532909', 'https://openalex.org/W1977450917', 'https://openalex.org/W1977910751', 'https://openalex.org/W1981397708', 'https://openalex.org/W1985147506', 'https://openalex.org/W1986348227', 'https://openalex.org/W1988144615', 'https://openalex.org/W1988327939', 'https://openalex.org/W1997952190', 'https://openalex.org/W2000047150', 'https://openalex.org/W2004903490', 'https://openalex.org/W2009281811', 'https://openalex.org/W2024896486', 'https://openalex.org/W2025656486', 'https://openalex.org/W2035144483', 'https://openalex.org/W2047132220', 'https://openalex.org/W2048185240', 'https://openalex.org/W2054244489', 'https://openalex.org/W2064679601', 'https://openalex.org/W2089781472', 'https://openalex.org/W2090604717', 'https://openalex.org/W2094933328', 'https://openalex.org/W2119810076', 'https://openalex.org/W2128903704', 'https://openalex.org/W2146001019', 'https://openalex.org/W2158313081', 'https://openalex.org/W2161767400', 'https://openalex.org/W2166959486', 'https://openalex.org/W2169348534', 'https://openalex.org/W2171194005'], 'related_works': ['https://openalex.org/W3185373682', 'https://openalex.org/W3126730168', 'https://openalex.org/W2582322860', 'https://openalex.org/W2462844398', 'https://openalex.org/W2146775426', 'https://openalex.org/W2118112957', 'https://openalex.org/W2058009067', 'https://openalex.org/W2030475312', 'https://openalex.org/W2025656486', 'https://openalex.org/W1522669222'], 'abstract_inverted_index': {'Thalidomide': [0], 'and': [1, 36, 44, 58, 67, 75, 113, 116, 147, 156, 172], 'the': [2, 24], 'immunomodulatory': [3, 38], 'drug,': [4, 39], 'lenalidomide,': [5, 148], 'are': [6], 'therapeutically': [7, 166], 'active': [8], 'in': [9, 60, 71, 81, 104, 111, 118, 126, 136, 139], 'hematological': [10], 'malignancies.': [11], 'The': [12], 'ubiquitously': [13], 'expressed': [14], 'E3': [15], 'ligase': [16], 'protein': [17, 150], 'cereblon': [18], '(CRBN)': [19], 'has': [20], 'been': [21], 'identified': [22], 'as': [23, 63, 65], 'primary': [25], 'teratogenic': [26], 'target': [27, 169], 'of': [28, 56, 79, 95, 170], 'thalidomide.': [29], 'Our': [30, 153], 'studies': [31, 159], 'demonstrate': [32], 'that': [33, 161], 'thalidomide,': [34], 'lenalidomide': [35, 57, 124, 171], 'another': [37], 'pomalidomide,': [40], 'bound': [41], 'endogenous': [42], 'CRBN': [43, 52, 80, 96, 149, 162], 'recombinant': [45], 'CRBN-DNA': [46], 'damage': [47], 'binding': [48], 'protein-1': [49], '(DDB1)': [50], 'complexes.': [51], 'mediated': [53], 'antiproliferative': [54], 'activities': [55], 'pomalidomide': [59, 76, 146], 'myeloma': [61, 106, 128, 141], 'cells,': [62, 107], 'well': [64], 'lenalidomide-': [66], 'pomalidomide-induced': [68], 'cytokine': [69], 'production': [70], 'T': [72], 'cells.': [73], 'Lenalidomide': [74], 'inhibited': [77], 'autoubiquitination': [78], 'HEK293T': [82], 'cells': [83, 142], 'expressing': [84], 'thalidomide-binding': [85, 91], 'competent': [86], 'wild-type': [87, 97], 'CRBN,': [88, 137], 'but': [89, 99], 'not': [90, 100], 'defective': [92], 'CRBN(YW/AA).': [93], 'Overexpression': [94], 'protein,': [98, 103], 'CRBN(YW/AA)': [101], 'mutant': [102], 'KMS12': [105], 'amplified': [108], 'pomalidomide-mediated': [109], 'reductions': [110], 'c-myc': [112], 'IRF4': [114], 'expression': [115], 'increases': [117], 'p21(WAF-1)': [119], 'expression.': [120], 'Long-term': [121], 'selection': [122], 'for': [123], 'resistance': [125], 'H929': [127], 'cell': [129], 'lines': [130], 'was': [131, 151], 'accompanied': [132], 'by': [133], 'a': [134, 164], 'reduction': [135], 'while': [138], 'DF15R': [140], 'resistant': [143], 'to': [144], 'both': [145], 'undetectable.': [152], 'biophysical,': [154], 'biochemical': [155], 'gene': [157], 'silencing': [158], 'show': [160], 'is': [163], 'proximate,': [165], 'important': [167], 'molecular': [168], 'pomalidomide.': [173]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2066713758', 'counts_by_year': [{'year': 2024, 'cited_by_count': 38}, {'year': 2023, 'cited_by_count': 74}, {'year': 2022, 'cited_by_count': 67}, {'year': 2021, 'cited_by_count': 92}, {'year': 2020, 'cited_by_count': 79}, {'year': 2019, 'cited_by_count': 68}, {'year': 2018, 'cited_by_count': 43}, {'year': 2017, 'cited_by_count': 51}, {'year': 2016, 'cited_by_count': 52}, {'year': 2015, 'cited_by_count': 55}, {'year': 2014, 'cited_by_count': 62}, {'year': 2013, 'cited_by_count': 45}, {'year': 2012, 'cited_by_count': 10}], 'updated_date': '2025-01-09T13:35:37.632980', 'created_date': '2016-06-24'}